Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 233Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 18Smart & Biggar

02 6Takeda Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2559302

Filing Date : 2004-12-15

Strength per Unit : 25 mg / 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-12-15

Date Granted : 2012-06-19

blank

02

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2622608

Filing Date : 2006-09-13

Strength per Unit : 25 mg / 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-09-13

Date Granted : 2014-08-19

blank

03

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2559302

Filing Date : 2004-12-15

Strength per Unit : 25 mg / 30 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-12-15

Date Granted : 2012-06-19

blank

04

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2622608

Filing Date : 2006-09-13

Strength per Unit : 25 mg / 30 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-09-13

Date Granted : 2014-08-19

blank

05

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2559302

Filing Date : 2004-12-15

Strength per Unit : 25 mg / 45 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-12-15

Date Granted : 2012-06-19

blank

06

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2622608

Filing Date : 2006-09-13

Strength per Unit : 25 mg / 45 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-09-13

Date Granted : 2014-08-19

blank

07

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2559302

Filing Date : 2004-12-15

Strength per Unit : 12.5 mg / 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-12-15

Date Granted : 2012-06-19

blank

08

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2622608

Filing Date : 2006-09-13

Strength per Unit : 12.5 mg / 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-09-13

Date Granted : 2014-08-19

blank

09

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2559302

Filing Date : 2004-12-15

Strength per Unit : 12.5 mg / 30 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-12-15

Date Granted : 2012-06-19

blank

10

arrow
Village de la Chimie
Not Confirmed
arrow
Village de la Chimie
Not Confirmed

ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE

Brand Name : OSENI

Patent Number : 2622608

Filing Date : 2006-09-13

Strength per Unit : 12.5 mg / 30 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-09-13

Date Granted : 2014-08-19

blank